熱門資訊> 正文
BriaCell Therapeutics定价850万美元股权发行
2024-09-12 01:17
- BriaCell Therapeutics (NASDAQ:BCTX) said it has priced its offering of 12.33M shares or pre-funded warrants at $0.69 apiece.
- The company expects total gross proceeds of ~$8.5M.
- Shares of the company were up 9% as the company also reported positive overall survival data from a Phase 2 study for its therapy Bria-IMT in the treatment of metastatic breast cancer.
More on Briacell Therapeutics
- BriaCell stock rockets 150% on positive Phase 2 data for Bria-IMT
- Seeking Alpha’s Quant Rating on Briacell Therapeutics
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
